Joseph D. Rosenblatt, M.D.
Professor and Chief
Division of Hematology/Oncology
|
| • |
NO CONFERENCE - THANKSGIVING HOLIDAY
November 25, 2009
|
| • |
Genetic Basis of Kidney Disease Burden Among Africian Americans
Rulan Parekh, M.D., M.S.
December 2, 2009
|
| • |
William Harrington Lecture
December 9, 2009
|
| • |
Worldwide Evolution of Resistance in Gram Negatives
Laurent Poirel, PhD
December 16, 2009
|
| • |
NO CONFERENCE - CHRISTMAS HOLIDAY
December 23, 2009
|
| • |
NO CONFERENCE - NEW YEAR'S HOLIDAY
December 30, 2009
|
| • |
To Be Announced
Paul Martin, MD
January 20, 2010
|
| • |
Atrial Fibrillation: Spectrum and Management Strategies
Robert J. Myerburg, M.D.
January 27, 2010
|
| • |
To Be Announced
Silvia Munoz-Price, MD
March 3, 2010
|
| • |
To Be Announced
Christopher O'Brien M.D.
March 10, 2010
|
| • |
To Be Announced
Flavia Mendes, M.D.
April 21, 2010
|
Click here
for Archived Events
|
|
CLL: Advances in Molecular Pathogenesis, Biomarker Development and Drug Development
Upon completion of this activity, physicians should be able to:
1. Explain molecular and phenotypic hetereogeneity in CLL and implications for therapy and prognosis.
2. Describe new molecular mechanisms in pathogenesis of common forms of CLL.
3. relate new advances in cytogenetics and biomarkers to therapeutic decisions.
|
|
|
|
